Study protocol of REGOSARC trial: activity and safety of regorafenib in advanced soft tissue sarcoma: a multinational, randomized, placebo-controlled, phase II trial

por Brodowicz, Thomas, Liegl-Atzwager, Bernadette, Tresch, Emmanuelle, Taieb, Sophie, Kramar, Andrew, Gruenwald, Viktor, Vanseymortier, Marie, Clisant, Stéphanie, Blay, Jean-Yves, Le Cesne, Axel, Penel, Nicolas
Publicado 2015